- Home
- LIME vs BHC Comparison
LIME vs BHC Comparison
Compare LIME & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIME | BHC |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2026 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LIME | BHC |
|---|---|---|
| Price | $38.97 | $6.74 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 323.2K | ★ 2.7M |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 5.47 | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.61 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.87 | $4.33 |
| 52 Week High | $44.38 | $8.00 |
Technical Indicators
Market Signals| Indicator | LIME | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 59.56 |
| Support Level | $36.00 | $5.48 |
| Resistance Level | $43.53 | $7.32 |
| Average True Range (ATR) | 2.69 | 0.31 |
| MACD | -0.50 | -0.04 |
| Stochastic Oscillator | 48.26 | 62.43 |
Price Performance
Historical ComparisonAbout LIME Neutron Holdings Inc. Common Stock
Neutron Holdings Inc is a micromobility company that provides rentals of shared electric scooters (e-scooters) and electric bicycles (e-bikes) through its platform (the Rider App) to be used for short distances in various cities and municipalities around the world.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.